StageZero Life Sciences Ltd T.SZLS

logic would somewhat dictate

[davewho]

if they moved the r/s timeline up then the timeline for rev growth and Aristotle could also be moving faster than originally thought. 
But sometimes the market and management moves aren't always logical. I've seen my share of bad r/s's
The BOD, management and the new institutional investors must have agreed now is the time. Hope they are right.
TMX still shows an active listing so not likely for that reason and no other filings I can see.
TD now shows EPS 0.01 and a low p/e of 9.5 which works out to earnings of about $4m. They don't need any money. The eps should jump to .08 after the r/s?

[capebretongirl]

Aristotle is the future player here, yet we are all speculating on its completion timeline - we have read corporate statements indicating end of 2020 or Q1 for roll out, yet we don't have the full picture of its current status - yes it may be moving faster than originally thought, but in this hospital COVID environment it could also be moving slower - point is we don't really know. 

[Liked2Think]

This is when Tripp can hold up on his word and keep investors informed. Why do this now?  There must be a reason.  I thought they would wait until closer to Q3 to consolidate and then have the awesome Q3 results to help hold the stock after it consolidates but they are doing it what like 6 weeks early? Would there be any reason to consolidate now so that we get the typical kind of run

[Eoganacht]

I'm guessing there will be another news release tomorrow.

[Liked2Think]

Hope you are right